A system for reviewing and monitoring cancer research protocols
Protocol Review and Monitoring System
['FUNDING_P30'] · UNIVERSITY OF ROCHESTER · NIH-11014536
This study is all about making sure that cancer research at the University of Rochester is safe and effective for patients like you, by having experts carefully review and approve the studies before they start.
Quick facts
| Phase | ['FUNDING_P30'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ROCHESTER (nih funded) |
| Locations | 1 site (ROCHESTER, UNITED STATES) |
| Trial ID | NIH-11014536 on ClinicalTrials.gov |
What this research studies
The Protocol Review and Monitoring System (PRMS) at the Wilmot Cancer Institute ensures that all cancer studies involving human subjects at the University of Rochester are scientifically sound and well-designed. This system involves a two-stage review process where Disease Working Groups assess the feasibility and priority of studies, followed by an independent committee that decides which studies can proceed. Patients can benefit from this rigorous oversight as it aims to enhance the quality and effectiveness of cancer research. The PRMS also emphasizes community engagement and collaboration to ensure that research aligns with patient needs.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals diagnosed with cancer who are interested in contributing to clinical trials and research.
Not a fit: Patients who are not diagnosed with cancer or are not eligible for clinical trials may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and scientifically validated cancer treatments for patients.
How similar studies have performed: Similar research approaches have shown success in improving the quality and outcomes of clinical trials in cancer treatment.
Where this research is happening
ROCHESTER, UNITED STATES
- UNIVERSITY OF ROCHESTER — ROCHESTER, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LINEHAN, DAVID C — UNIVERSITY OF ROCHESTER
- Study coordinator: LINEHAN, DAVID C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: anti-cancer research, cancer clinical trial, cancer research, Cancers